Medigen Biotechnology Corporation(TW:3176)
30.10-3.15 (-9.47%)
TW:3176
Medigen Biotechnology Corporation ownership
30.10
At close:-3.15 (-9.47%)
Medigen Biotechnology Corporation (3176) Ownership - Who Owns Medigen Biotechnology Corporation?
Medigen Biotechnology Corporation (3176) Ownership Overview
- 2.51% ETFs
- 97.49% Public Companies and Individual Investors
The ownership structure of Medigen Biotechnology Corporation (TW:3176) stock is a mix of institutional, retail, and individual investors. Approximately 2.51% of the company’s stock is owned by Institutional Investors, and 97.49% is owned by Public Companies and Individual Investors.
The ownership structure of Medigen Biotechnology Corporation (TW:3176) stock is a mix of institutional, retail, and individual investors. Approximately 2.51% of the company’s stock is owned by Institutional Investors, and 97.49% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 3,481,126 | Institution | 2.50% | 3,181,749 |
| State Street | 14,000 | Institution | 0.01% | 12,796 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total International Stock ETF, VXUS ETF | 1,500,797 | Institution | 1.08% | 1,778,535 |
| Vanguard FTSE Emerging Markets ETF, VWO ETF | 1,470,000 | Institution | 1.06% | 1,742,039 |
| Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF | 423,329 | Institution | 0.30% | 501,670 |
| Vanguard Total World Stock ETF, VT ETF | 65,000 | Institution | 0.05% | 77,029 |
| Vanguard ESG International Stock ETF, VSGX ETF | 18,000 | Institution | 0.01% | 18,157 |
| SPDR S&P Emerging Asia Pacific ETF, GMF ETF | 14,000 | Institution | 0.01% | 14,122 |
| Vanguard Funds PLC - Vanguard ESG Emerging Markets All Cap UCITS ETF AccumUSD, DE:V3MA ETF | 1,000 | Institution | <0.01% | 1,184 |
| Vanguard ESG Emerging Markets All Cap UCITS ETF USD, DE:V3ML ETF | 1,000 | Institution | <0.01% | 1,184 |
| Vanguard FTSE Global Small-Cap UCITS ETF Accun USD, NL:VSML ETF | 1,000 | Institution | <0.01% | 1,184 |
| Vanguard Funds plc - Vanguard FTSE Global Small-Cap UCITS ETF, GB:VSMD ETF | 1,000 | Institution | <0.01% | 1,184 |
FAQ
What percentage of Medigen Biotechnology Corporation (TW:3176) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.51% of Medigen Biotechnology Corporation (TW:3176) stock is held by institutional investors.
What percentage of Medigen Biotechnology Corporation (TW:3176) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.49% of Medigen Biotechnology Corporation (TW:3176) stock is held by public companies and individual investors.
Who owns the most shares of Medigen Biotechnology Corporation (TW:3176)?
Vanguard owns the most shares of Medigen Biotechnology Corporation (TW:3176).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
